L-DOPA Is an Endogenous Ligand for OA1

Por Lopez, Vanessa M, Decatur, Christina L, Stamer, W. Daniel, Lynch, Ronald M, McKay, Brian S
Publicado em 2008

Driver Mutations in Uveal Melanoma: Associations With Gene Expression Profile and Patient Outcomes

Por Decatur, Christina L., Ong, Erin, Garg, Nisha, Anbunathan, Hima, Bowcock, Anne M., Field, Matthew G., Harbour, J. William
Publicado no JAMA Ophthalmol (2016)

Microincisional vitrectomy for retinal detachment in I-125 brachytherapy-treated patients with posterior uveal malignant melanoma

Por Lonngi, Marcela, Houston, Samuel K, Murray, Timothy G, Sisk, Robert A, Decatur, Christina L, Cavalcante, Milena, Markoe, Arnold M
Publicado em 2013

Punctuated evolution of canonical genomic aberrations in uveal melanoma

Por Field, Matthew G., Durante, Michael A., Anbunathan, Hima, Cai, Louis Z., Decatur, Christina L., Bowcock, Anne M., Kurtenbach, Stefan, Harbour, J. William
Publicado no Nat Commun (2018)

PRAME as an independent biomarker for metastasis in uveal melanoma

Por Field, Matthew G., Decatur, Christina L., Kurtenbach, Stefan, Gezgin, Gülçin, van der Velden, Pieter A., Jager, Martine J., Kozak, Kaleigh N., Harbour, J. William
Publicado no Clin Cancer Res (2016)

Epigenetic reprogramming and aberrant expression of PRAME are associated with increased metastatic risk in Class 1 and Class 2 uveal melanomas

Por Field, Matthew G., Durante, Michael A., Decatur, Christina L., Tarlan, Bercin, Oelschlager, Kristen M., Stone, John F., Kuznetsov, Jeffim, Bowcock, Anne M., Kurtenbach, Stefan, Harbour, J. William
Publicado no Oncotarget (2016)

Intravitreal injection analysis at the Bascom Palmer Eye Institute: evaluation of clinical indications for the treatment and incidence rates of endophthalmitis

Por Cavalcante, Ludimila L, Cavalcante, Milena L, Murray, Timothy G, Vigoda, Michael M, Piña, Yolanda, Decatur, Christina L, Davis, R Prince, Olmos, Lisa C, Schefler, Amy C, Parrott, Michael B, Alliman, Kyle J, Flynn, Harry W, Moshfeghi, Andrew A
Publicado em 2010